CVR: 39492059
Secondary names: Oresund Pharma ApS, Oresund ApS
Previous names: Øresund Pharma IVS
Øresund Pharma ApS is a Danish company of the type Anpartsselskab based in Nordhavn, founded in 2018. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Øresund Pharma IVS. The management consists of Svend Aage Johansen and Patrick Halborg Cohn. The company is owned by Machpali ApS and ESH Holding 2019 ApS. The company has 1 employee. In 2025, the company reported a gross profit of DKK 39,702,011 and a net result of DKK 6,466,876 compared with DKK 13,707,320 the year before. Equity amounted to DKK 44,617,595.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at udvikle og kommercialisere farmaceutiske lægemidler og dermed forbunden virksomhed.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 39.7 mio. | 6.5 mio. | 127.6 mio. | 44.6 mio. | 16 | |
| 2024 | 39.6 mio. | 13.7 mio. | 81.1 mio. | 38.2 mio. | 11 | |
| 2023 | 38.3 mio. | 16.8 mio. | 42.5 mio. | 24.4 mio. | 9 | |
| 2022 | 17.2 mio. | 4.3 mio. | 31 mio. | 7.7 mio. | 6 | |
| 2021 | 7.3 mio. | 281 t. | 23.9 mio. | 3.4 mio. | 5 | |
| 2020 | 2.8 mio. | -86 t. | 23 mio. | 3.1 mio. | 4 | |
| 2019 | 4.9 mio. | 2.6 mio. | 14.4 mio. | 2.7 mio. | 3 |
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationCompared to 412 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
2 public tenders won
Sources: TED (the EU tender database) and udbud.dk
Screen owners and management against the Danish FSA's official PEP lists
Øresund Pharma ApS has won the tender "Bekendtgørelse med henblik på frivillig forudgående gennemsigtighed - rammeaftale vedrørende indkøb af fentanyl placebo" issued by Danish Ministry of Defence Acquisition and Logistics Organisation worth 5,100,000 DKK.
Øresund Pharma ApS has published its annual report for 2025. Gross profit came to DKK 39,702,011, and the net result was DKK 6,466,876.
Øresund Pharma ApS has won the tender "Udbudsnummer 1" issued by Amgros I/S worth 26,800,000 DKK.
Contact info changed: new email: [email protected], new website: www.oresundpharma.com (January 14, 2026).
As of August 19, 2025, BDO Statsautoriseret Revisionspartnerselskab has been appointed auditor of Øresund Pharma ApS.
As of August 19, 2025, BDO Holding VII, statsautoriseret revisionsaktieselskab has stepped down as auditor of Øresund Pharma ApS.
Øresund Pharma ApS has published its annual report for 2024. Gross profit came to DKK 39,622,065, and the net result was DKK 13,707,320.
As of April 1, 2024, Svend Aage Johansen is registered as director of Øresund Pharma ApS.
Øresund Pharma ApS has published its annual report for 2023. Gross profit came to DKK 38,259,550, and the net result was DKK 16,750,969.
Øresund Pharma ApS has published its annual report for 2022. Gross profit came to DKK 17,238,144, and the net result was DKK 4,302,384.
Øresund Pharma ApS has published its annual report for 2021. Gross profit came to DKK 7,275,387, and the net result was DKK 281,255.
As of December 9, 2021, BDO Holding VII, statsautoriseret revisionsaktieselskab has been appointed auditor of Øresund Pharma ApS.
As of December 9, 2021, CHRISTENSEN KJÆRULFF STATSAUTORISERET REVISIONSAKTIESELSKAB has stepped down as auditor of Øresund Pharma ApS.
Øresund Pharma ApS has published its annual report for 2020. Gross profit came to DKK 2,754,994, and the net result was DKK -86,083.
As of December 18, 2020, Machpali ApS is registered as an owner of Øresund Pharma ApS with an ownership share of 90%.
As of December 18, 2020, ESH Holding 2019 ApS is registered as an owner of Øresund Pharma ApS with an ownership share of 10%.
Øresund Pharma ApS has published its annual report for 2019. Gross profit came to DKK 4,932,387, and the net result was DKK 2,568,553.
Øresund Pharma ApS has published its interim report for the period April 17, 2018 – December 31, 2018.
As of June 19, 2018, CHRISTENSEN KJÆRULFF STATSAUTORISERET REVISIONSAKTIESELSKAB has been appointed auditor of Øresund Pharma ApS.
On June 19, 2018, the company changed its name from Øresund Pharma IVS to Øresund Pharma ApS.
As of April 17, 2018, Patrick Halborg Cohn is registered as adm. dir. of Øresund Pharma ApS.
Øresund Pharma ApS was founded on April 17, 2018.
Companies in the same industry and area
CVR 19835081
CVR 21327581
CVR 46124723
CVR 45346951
CVR 35451307
companydata.dk